title: Re: Adaptive therapy for androgen-independent prostate cancer: a randomized selection trial of four regimens.
authors.forename: Andrew J
authors.initials: AJ
authors.lastname: Armstrong
authors.forename: Elizabeth L
authors.initials: EL
authors.lastname: Garrett-Mayer
authors.forename: Mario
authors.initials: M
authors.lastname: Eisenberger
mesh_terms: D000728:Androgens / Q000378:metabolism; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018572:Disease-Free Survival; D000077143:Docetaxel; D004961:Estramustine / Q000008:administration & dosage; D006801:Humans; D008297:Male; D008942:Mitoxantrone / Q000008:administration & dosage; D011241:Prednisone / Q000008:administration & dosage; D011471:Prostatic Neoplasms / Q000188:drug therapy* / Q000378:metabolism; D016032:Randomized Controlled Trials as Topic; D015983:Selection Bias; D016019:Survival Analysis; D043823:Taxoids / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D000728:Androgens; D043823:Taxoids; D000077143:Docetaxel; D004961:Estramustine; D008942:Mitoxantrone; D011241:Prednisone